Page last updated: 2024-08-17

cysteamine and cholestyramine resin

cysteamine has been researched along with cholestyramine resin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frants, RR; Havekes, LM; Hoffer, MJ; Kibirige, MS; Naoumova, RP; Niththyananthan, S; Thompson, GR	1

Other Studies

1 other study(ies) available for cysteamine and cholestyramine resin

Article	Year
Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia. Atherosclerosis, 1996, Aug-02, Volume: 124, Issue:2 Topics: Adult; Anticholesteremic Agents; Apolipoproteins E; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Cysteamine; Dinucleotide Repeats; DNA; Electrophoresis; Exons; Female; Fenofibrate; Genotype; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Immunoblotting; Male; Nuclear Family; Phenotype; Point Mutation; Radiation-Protective Agents; Triglycerides	1996

Article

Year

Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.

Atherosclerosis, 1996, Aug-02, Volume: 124, Issue:2

Topics: Adult; Anticholesteremic Agents; Apolipoproteins E; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Cysteamine; Dinucleotide Repeats; DNA; Electrophoresis; Exons; Female; Fenofibrate; Genotype; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Immunoblotting; Male; Nuclear Family; Phenotype; Point Mutation; Radiation-Protective Agents; Triglycerides

1996